Nanometics LLC

Nanometics is developing nontoxic transition state inhibitors for triple negative breast cancer that work through a novel target

  • Stage Product In Development
  • Industry Biotechnology
  • Location New York City, NY, USA
  • Currency USD
  • Founded January 2007
  • Employees 5
  • Website nanometicslab.com

Company Summary

Nanometics is a biotechnology company focused on developing oral medications for diseases with high unmet medical need. The company has received over $3.1 million in NIH funding in the past three years, and focuses on oncology and hematology projects.

Team

Advisors

  • Henry Coleman, Ph.D.
    Lawyer
    Unconfirmed
    Eric Mendelsohn, CPA
    Accountant
    Unconfirmed

Previous Investors

  • National Heart Lung and Blood Institute
    Unconfirmed
    National Cancer Institute
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free